Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate After Cure of Primary Hyperparathyroidism
NCT00359385Phase 4Withdrawn
- Sponsor
- Columbia University
- Start
- Jul 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alendronate in primary hyperparathyroidism (PHPT), sponsored by Columbia University. Planned start Jul 2006; status: withdrawn.
02
Drugs
alendronate
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT00359385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359385.